Literature DB >> 23022184

Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.

Xiuping Zhou1, Qingming Meng, Xuebin Xu, Tongle Zhi, Qiong Shi, Yong Wang, Rutong Yu.   

Abstract

The function of Bex2, a member of the Brain Expressed X-linked gene family, in glioma is controversial and its mechanism is largely unknown. We report here that Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase (JNK) pathway. The expression level of Bex2 is markedly increased in glioma tissues. We observed that Bex2 over-expression promotes cell proliferation, while down-regulation of Bex2 inhibits cell growth. Furthermore, Bex2 down-regulation promotes cell apoptosis and activates the JNK pathway; these effects were abolished by administration of the JNK specific inhibitor, SP600125. Thus, Bex2 may be an important player during the development of glioma.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022184     DOI: 10.1016/j.bbrc.2012.09.100

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Gene targeting study reveals unexpected expression of brain-expressed X-linked 2 in endocrine and tissue stem/progenitor cells in mice.

Authors:  Keiichi Ito; Satoshi Yamazaki; Ryo Yamamoto; Yoko Tajima; Ayaka Yanagida; Toshihiro Kobayashi; Megumi Kato-Itoh; Shigeru Kakuta; Yoichiro Iwakura; Hiromitsu Nakauchi; Akihide Kamiya
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

2.  Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway.

Authors:  Qingming Meng; Tongle Zhi; Yuewen Chao; Er Nie; Xuebin Xu; Qiong Shi; Lei Hua; Lei Wang; Wenjian Zhan; Yong Wang; Xiuping Zhou; Rutong Yu
Journal:  J Mol Neurosci       Date:  2014-01-04       Impact factor: 3.444

3.  Aqueous humor proteomic analysis of acute angle-closure glaucoma with visual field loss.

Authors:  Jiyu Xu; Liangliang Zhao; Xiang Liu; Haidan Sun; Xiaoyan Liu; Zhengguang Guo; Ying Wang; Wei Sun
Journal:  Ann Transl Med       Date:  2021-11

4.  Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme.

Authors:  Adilai Aisa; Yinuo Tan; Xinyu Li; Ding Zhang; Yun Shi; Ying Yuan
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

5.  Hugl-1 inhibits glioma cell growth in intracranial model.

Authors:  Xuejiao Liu; Dong Lu; Peng Ma; Huaqiang Liu; Yuewen Cao; Ben Sang; Xianlong Zhu; Qiong Shi; Jinxia Hu; Rutong Yu; Xiuping Zhou
Journal:  J Neurooncol       Date:  2015-09-04       Impact factor: 4.130

6.  Transcriptome Analysis of Bovine Ovarian Follicles at Predeviation and Onset of Deviation Stages of a Follicular Wave.

Authors:  Pengfei Li; Jinzhu Meng; Wenzhong Liu; George W Smith; Jianbo Yao; Lihua Lyu
Journal:  Int J Genomics       Date:  2016-03-21       Impact factor: 2.326

7.  BEX2 promotes tumor proliferation in colorectal cancer.

Authors:  Yeting Hu; Qian Xiao; Haiyan Chen; Jinjie He; Yinuo Tan; Yue Liu; Zhanhuai Wang; Qi Yang; Xiangfeng Shen; Yu Huang; Ying Yuan; Kefeng Ding
Journal:  Int J Biol Sci       Date:  2017-02-12       Impact factor: 6.580

8.  Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.

Authors:  Wei Gao; John Zeng-Hong Li; Si-Qi Chen; Chiao-Yun Chu; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  J Exp Clin Cancer Res       Date:  2016-06-13

9.  Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition.

Authors:  Jin-Kwan Lee; Janet Lee; Heounjeong Go; Chang Geun Lee; Suhyeon Kim; Hyun-Soo Kim; Hyeseong Cho; Kyeong Sook Choi; Geun-Hyoung Ha; Chang-Woo Lee
Journal:  Cell Death Dis       Date:  2016-08-11       Impact factor: 8.469

10.  Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development.

Authors:  Fuqiang Huang; Pei Cai; Yanan Wang; Xian Zhou; Hongyu Chen; Wenjun Liao; Yilei Mao; Xiaojun Zha; Hongbing Zhang; Zhongdong Hu
Journal:  Oncotarget       Date:  2017-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.